PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 95,953 shares, a growth of 55.4% from the July 30th total of 61,730 shares. Based on an average daily trading volume, of 361,187 shares, the days-to-cover ratio is presently 0.3 days.

PharmaTher Trading Down 7.0%

PharmaTher stock opened at $0.04 on Thursday. PharmaTher has a 12-month low of $0.03 and a 12-month high of $0.30. The business’s 50-day moving average price is $0.04 and its two-hundred day moving average price is $0.05.

About PharmaTher

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.